According to its financial network, Hengrui Pharma is a private enterprise, not a state-owned enterprise. The controlling shareholder is jiangsu hengrui Pharmaceutical Group Co., Ltd., and the ultimate controller is Sun Piaoyang, a private enterprise. The company is one of the largest R&D and production bases of anti-tumor drugs, surgical drugs and contrast agents in China.